- Home
- MGLD vs CCEL Comparison
MGLD vs CCEL Comparison
Compare MGLD & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGLD
- CCEL
- Stock Information
- Founded
- MGLD 1996
- CCEL 1989
- Country
- MGLD United States
- CCEL United States
- Employees
- MGLD N/A
- CCEL N/A
- Industry
- MGLD Finance/Investors Services
- CCEL Managed Health Care
- Sector
- MGLD Finance
- CCEL Health Care
- Exchange
- MGLD Nasdaq
- CCEL Nasdaq
- Market Cap
- MGLD 37.9M
- CCEL 39.9M
- IPO Year
- MGLD N/A
- CCEL 1997
- Fundamental
- Price
- MGLD $0.82
- CCEL $4.96
- Analyst Decision
- MGLD
- CCEL Strong Buy
- Analyst Count
- MGLD 0
- CCEL 1
- Target Price
- MGLD N/A
- CCEL $8.50
- AVG Volume (30 Days)
- MGLD 8.7K
- CCEL 7.7K
- Earning Date
- MGLD 09-17-2025
- CCEL 07-15-2025
- Dividend Yield
- MGLD N/A
- CCEL 12.63%
- EPS Growth
- MGLD N/A
- CCEL N/A
- EPS
- MGLD N/A
- CCEL N/A
- Revenue
- MGLD $31,205,000.00
- CCEL $31,988,783.00
- Revenue This Year
- MGLD N/A
- CCEL $1.75
- Revenue Next Year
- MGLD N/A
- CCEL N/A
- P/E Ratio
- MGLD N/A
- CCEL N/A
- Revenue Growth
- MGLD N/A
- CCEL 1.10
- 52 Week Low
- MGLD $0.70
- CCEL $4.68
- 52 Week High
- MGLD $2.10
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- MGLD 45.83
- CCEL 50.13
- Support Level
- MGLD $0.83
- CCEL $4.75
- Resistance Level
- MGLD $0.90
- CCEL $5.24
- Average True Range (ATR)
- MGLD 0.07
- CCEL 0.28
- MACD
- MGLD -0.00
- CCEL 0.01
- Stochastic Oscillator
- MGLD 16.40
- CCEL 45.16
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.